Baicalein Prevents 6-Hydroxydopamine-Induced Dopaminergic Dysfunction and Lipid Peroxidation in Mice

Baicalein Prevents 6-Hydroxydopamine-Induced Dopaminergic Dysfunction and Lipid Peroxidation in Mice

The effects of baicalein on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity were evaluated. Intracerebroventricularly (i.c.v.) injection of 6-OHDA was done to young mice. Baicalein was administered intraperitoneally 30 min before and 90 min after i.c.v. injection. Animals received further injection...

Full description

Bibliographic Details
Main Authors:	Heh-In Im, Wan Seok Joo, Eunjoo Nam, Eun-sun Lee, Yu-jin Hwang, Yong Sik Kim
Format:	Article
Language:	English
Published:	Elsevier 2005-01-01
Series:	Journal of Pharmacological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S134786131932198X

Similar Items

Dopaminergic Neuroprotection with Ginkgolide in 6-Hydroxydopamine Rat Parkinson’s Disease Model
by: Alireza Moghadam, et al.
Published: (2019-03-01)

Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson’s disease
by: Kuo-Jen Wu, et al.
Published: (2023-05-01)

Baicalein Prevents 6-Hydroxydopamine-Induced Mitochondrial Dysfunction in SH-SY5Y Cells via Inhibition of Mitochondrial Oxidation and Up-Regulation of DJ-1 Protein Expression
by: Yue-Hua Wang, et al.
Published: (2013-11-01)

Alleviation of Methamphetamine Sensitization by Partially Lesioning Dopaminergic Terminals with 6-Hydroxydopamine in Nucleus Accumbens
by: Shu-Chun Chen, et al.
Published: (2021-11-01)

Protective Effect of Amber Extract on Human Dopaminergic Cells against 6-Hydroxydopamine-Induced Neurotoxicity
by: Yuening Luo, et al.
Published: (2022-03-01)

The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy
by: Santiago Rodríguez-Carreiro, et al.
Published: (2023-08-01)

Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.
by: Katsuaki Suzuki, et al.
Published: (2010-02-01)

Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism
by: Song Ju-Xian, et al.
Published: (2012-01-01)

Baicalein prevents 6-OHDA/ascorbic acid-induced calcium-dependent dopaminergic neuronal cell death
by: Sheng-Fang Wang, et al.
Published: (2017-08-01)

NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson’s disease
by: Li Cheng, et al.
Published: (2018-08-01)

Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.
by: David Reyes-Corona, et al.
Published: (2017-01-01)

Adeno-Associated Viral Delivery of GDNF Promotes Recovery of Dopaminergic Phenotype following a Unilateral 6-Hydroxydopamine Lesion
by: John Mcgrath, et al.
Published: (2002-04-01)

Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo
by: Ming-Shu Mo, et al.
Published: (2018-08-01)

Epigenetic Dysfunction of Neurodegenerative Diseases, MeCP2 and More
by: Heh-In Im
Published: (2022-11-01)

Ferroptosis: whERe is the critical site of lipid peroxidation?
by: Wan Seok Yang
Published: (2023-05-01)

The interaction between cucurbit[8]uril and baicalein and the effect on baicalein properties
by: Xiaodong Zhang, et al.
Published: (2020-01-01)

Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease
by: Weizhao Chen, et al.
Published: (2022-05-01)

Synthesis and Biochemical Evaluation of Baicalein Prodrugs
by: Sang-Hyun Son, et al.
Published: (2021-09-01)

Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
by: Palmiter Richard D, et al.
Published: (2005-12-01)

Electroacupuncture Produces the Sustained Motor Improvement in 6-Hydroxydopamine-Lesioned Mice.
by: Yan Yu, et al.
Published: (2016-01-01)

A time-course study of urodynamic analyses in rat models with dopaminergic depletion induced through unilateral and bilateral 6-hydroxydopamine injections
by: Chellappan Praveen Rajneesh, et al.
Published: (2023-03-01)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
by: Katrine Fabricius, et al.
Published: (2017-12-01)

Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease
by: Venissa Machado, et al.
Published: (2016-04-01)

Baicalein and its underlying mechanism as a protector against liver injury induced by cisplatin in mice
by: Chengwei Niu, et al.
Published: (2017-01-01)

Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
by: V. Rizelio, et al.
Published: (2010-01-01)

Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice
by: Juntao Cui, et al.
Published: (2024-02-01)

"EFFECT OF CIMETIDINE AND RANITIDINE ON LIPID PROFILE AND LIPID PEROXIDATION IN γ-IRRADIATED MICE"
by: S. Kabodanian Ardestani, et al.
Published: (2004-06-01)

"EFFECT OF CIMETIDINE AND RANITIDINE ON LIPID PROFILE AND LIPID PEROXIDATION IN γ-IRRADIATED MICE"
by: A. Kariminia2 Z.Tavakoli, et al.
Published: (2004-08-01)

Effect of Baicalein on GLUT4 Translocation in Adipocytes of Diet-Induced Obese Mice
by: Wen Min, et al.
Published: (2018-10-01)

N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson’s Disease Rat Model
by: Rita Caridade-Silva, et al.
Published: (2023-06-01)

The relationship between the location of a lesion in the striatal dopaminergic innervation and its behavioral manifestation in a 6-hydroxydopamine-induced model of Parkinson's disease in rats
by: Alla V. Stavrovskaya, et al.
Published: (2021-06-01)

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease
by: Edward J. R. Fletcher, et al.
Published: (2019-12-01)

Dopaminergic neurodegeneration in the substantia nigra is associated with olfactory dysfunction in mice models of Parkinson’s disease
by: Yu Yuan, et al.
Published: (2023-10-01)

Peculiarities of lipid and protein peroxidation in autoimmune thyroiditis with and without mild thyroid dysfunction
Published: (2011-12-01)

Baicalein and baicalin as Zika virus inhibitors
by: Oo, Adrian, et al.
Published: (2019)

Potential therapeutic effects of baicalin and baicalein
by: Kamyar Sabry, et al.
Published: (2024-01-01)

Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease
by: Jiewen Qiu, et al.
Published: (2023-01-01)

Lipid peroxidation changes induced by dibutyl phthalate in allergic asthma mice
by: Yan LI, et al.
Published: (2023-02-01)

Lipid-induced peroxidation in the intestine is involved in glucose homeostasis imbalance in mice.
by: Matteo Serino, et al.
Published: (2011-01-01)

Lipid Peroxidation in Neurodegeneration
by: Consuelo Cháfer-Pericás
Published: (2021-03-01)